Back to Search
Start Over
Effect of qualitative and quantitative nutritional plan on gene expression in obese patients in secondary prevention for cardiovascular disease
- Source :
- Clinical Nutrition ESPEN. 41:351-359
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Diet is a modifiable risk factor, which may influence the gene expression and the concentration of inflammatory biomarkers related to obesity and atherosclerosis. In this substudy from Brazilian Cardioprotective Nutritional (BALANCE) Program, we hypothesized that a nutritional intervention based on the usual Brazilian diet modulates the expression of genes involved with atherosclerosis and inflammatory biomarkers in male patients, in the secondary prevention for cardiovascular disease.Six male patients, aged 45 years or older, obese, were selected to follow a qualitative-quantitative food plan for 6 months. Glycemia, insulinemia, lipid profile, plasma concentration of inflammatory biomarkers (interleukin (IL) -1β), IL-6, IL-8, IL-10, IL-12, tumor necrosis factor alpha, C-reactive protein and adiponectin, and expression of 84 atherosclerosis-related genes in total peripheral blood cells, were measured.After nutritional intervention, the participants reduced weight (p 0.04), waist circumference (p 0.04), Homeostasis Model Assessment index for insulin resistance (p = 0.046) and overall leukocyte count (p = 0.046) and neutrophils (p = 0.028). There was no significant modification in the plasma concentration of the inflammatory biomarkers, however, there was a significant increase in the expression of Apo A1 (p = 0.011), ELN (p = 0.017) and IL4 (p = 0.037) genes.The BALANCE Program, the qualitative-quantitative food plan composed of Brazilian usual foods, did not reduce the concentration of inflammatory biomarkers, but increased in total peripheral blood cells the expression of genes involved in reducing the risk of cardiometabolic in obese patients, in secondary prevention for cardiovascular disease. The clinical trial is registered at https://clinicaltrials.gov/ and the unique identifier is NCT01620398.
- Subjects :
- Male
0301 basic medicine
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
Gene Expression
030209 endocrinology & metabolism
Disease
03 medical and health sciences
0302 clinical medicine
Internal medicine
Secondary Prevention
medicine
Humans
Obesity
Risk factor
030109 nutrition & dietetics
Nutrition and Dietetics
medicine.diagnostic_test
Adiponectin
business.industry
Interleukin
medicine.disease
Clinical trial
C-Reactive Protein
Cardiovascular Diseases
Tumor necrosis factor alpha
business
Lipid profile
Subjects
Details
- ISSN :
- 24054577 and 01620398
- Volume :
- 41
- Database :
- OpenAIRE
- Journal :
- Clinical Nutrition ESPEN
- Accession number :
- edsair.doi.dedup.....9cbb95fbb62798c0d5811fc47c18f38a
- Full Text :
- https://doi.org/10.1016/j.clnesp.2020.11.002